{"nct_id":"NCT03580356","title":"A Phase III Study of and Efficacy of Ligelizumab in the Treatment of CSU in Adolescents and Adults Inadequately Controlled With H1-antihistamines.","status":"COMPLETED","status_verified_date":"2025-01","start_date":"2018-10-20","start_date_type":"ACTUAL","primary_completion_date":"2021-06-22","primary_completion_date_type":"ACTUAL","completion_date":"2022-06-14","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["NVS"]}